Effective of verapamil combination with vacuum for treatment of peyronie's disease

Phase 3

• Conditions: Peyronie disease.; Disorder of penis, unspecified; N48.9

• Registration Number: IRCT20200316046786N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 30

Inclusion Criteria

All patient have peyronie's disease at least 6 months
All patient have 90 c curvature in penis.

Exclusion Criteria

Patient have plaque in all part of penis
patient have ventral curvature.
patient have erection dysfunction with peyronie disease that have not respond to oral agent or ICI.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diffrence in curvature of penis picture before and after trial. Timepoint: before trial and 6 week after trial. Method of measurement: patient take photo from his penis curvature.